Alumis, Inc. (ALMS)
20.74
+0.73
(+3.65%)
USD |
NASDAQ |
Jun 10, 10:13
Alumis EPS Diluted (TTM) : -1.921 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Nektar Therapeutics | -8.420 |
| Bristol Myers Squibb Co. | 3.563 |
| Amylyx Pharmaceuticals, Inc. | -1.507 |
| Aardvark Therapeutics, Inc. | -3.209 |
| Johnson & Johnson | 8.649 |